UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precision Medicine in Hormone Receptor-Positive Breast Cancer

Frontiers in oncology, 2018-05, Vol.8, p.144-144

2018

Volltextzugriff (PDF)

Network-guided prediction of aromatase inhibitor response in breast cancer

PLoS computational biology, 2019-02, Vol.15 (2), p.e1006730-e1006730

2019

Volltextzugriff (PDF)

Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib

Breast cancer : basic and clinical research, 2020, Vol.14, p.1178223420944864-1178223420944864

2020

Volltextzugriff (PDF)

191 Association of immune related adverse events with the efficacy of immune checkpoint inhibitors in metastatic renal cell carcinoma

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A112-A113

2020

Volltextzugriff (PDF)

Palliative Care Training during Fellowship: A National Survey of U.S. Hematology and Oncology Fellows

Journal of palliative medicine, 2015-09, Vol.18 (9), p.747-751

2015

Volltextzugriff (PDF)

The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets

Journal of orthopaedic research, 2002-07, Vol.20 (4), p.643-647

2002

Volltextzugriff (PDF)

Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial Carcinoma

Bladder cancer, 2021-01, Vol.7 (2), p.143-148

2021

Volltextzugriff (PDF)

Protein Gene Product 9.5 (PGP 9.5) Is Not a Specific Marker of Neural and Nerve Sheath Tumors: An Immunohistochemical Study of 95 Mesenchymal Neoplasms

Modern pathology, 2003-10, Vol.16 (10), p.963-969

2003

Volltextzugriff (PDF)

Understanding testing for and treatment of homologous recombination repair (HRR)-mutated metastatic castrate-resistant prostate cancer (mCRPC): A quality initiative by Integra Connect (IC) PrecisionQ

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17052-e17052

2023

Volltextzugriff (PDF)

Role of sarA in the Pathogenesis of Staphylococcus aureus Musculoskeletal Infection

Infection and Immunity, 2003-01, Vol.71 (1), p.516-523

2003

Volltextzugriff (PDF)

Patient Understanding and Impression of Hematology/Oncology Fellows

The American journal of the medical sciences, 2014-09, Vol.348 (3), p.262-264

2014

Volltextzugriff (PDF)

Comparison of objective criteria for set-up planning in complementary flexible manufacturing systems

Computers & industrial engineering, 2007-08, Vol.53 (1), p.17-29

2007

Volltextzugriff (PDF)

BRCA and homologous recombination repair deficiency testing in advanced ovarian cancer: A real-world data analysis

Gynecologic oncology, 2024-11, Vol.190, p.S156-S157

2024

Volltextzugriff (PDF)

Patterns in maintenance therapy use in advanced ovarian cancer patients: Real-world data analysis

Gynecologic oncology, 2024-11, Vol.190, p.S333-S333

2024

Volltextzugriff (PDF)

Use of poly (adp-ribose) polymerase inhibitors (PARPi) in metastatic castration resistant prostate cancer (mCRPC) patients stratified by homologous recombination repair mutations

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17053-e17053

2023

Volltextzugriff (PDF)

Supporting high-risk oncology patients with an outpatient transitional care management program

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.313-313

2022

Volltextzugriff (PDF)

Understanding testing for and treatment of homologous recombination repair (HRR)-mutated metastatic castrate-resistant prostate cancer (mCRPC): A quality initiative by Integra Connect PrecisionQ

JCO oncology practice, 2023-11, Vol.19 (11_suppl), p.581-581

2023

Volltextzugriff (PDF)

Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.TPS238-TPS238

2024

Volltextzugriff (PDF)

A phase 2, multicenter, parallel-group, open-label study of vudalimab (XmAb20717), a PD-1 x CTLA-4 bispecific antibody, alone or in combination with chemotherapy or targeted therapy in patients with molecularly defined subtypes of metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS5097-TPS5097

2022

Volltextzugriff (PDF)

Prognostic value of the “surprise question” among UPMC Hillman Cancer Center patients with select stage IV cancer diagnoses

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.25-25

2020

Volltextzugriff (PDF)

Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases

JAMA oncology, 2017-05, Vol.3 (5), p.666

2017

Volltextzugriff (PDF)

The osteoclast-type giant cell rich carcinoma of urinary bladder: A case series

Pathology, research and practice, 2022-11, Vol.239, p.154164-154164, Article 154164

2022

Volltextzugriff (PDF)

FGFR2/3 genomic alterations (GA) in cell-free (cf)DNA from patients (pts) with advanced urothelial carcinoma (aUC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.565-565

2020

Volltextzugriff (PDF)

Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future

JCO oncology practice, 2023-05, Vol.19 (5), p.251-259

2023

Volltextzugriff (PDF)

Characterization of a rabbit model of staphylococcal osteomyelitis

Journal of orthopaedic research, 1997-05, Vol.15 (3), p.414-421

1997

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(186)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(227)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Precision Medicine in Hormone Receptor-Positive Breast Cancer

Network-guided prediction of aromatase inhibitor response in breast cancer

Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib

191 Association of immune related adverse events with the efficacy of immune checkpoint inhibitors in metastatic renal cell carcinoma

Palliative Care Training during Fellowship: A National Survey of U.S. Hematology and Oncology Fellows

The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets

Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial Carcinoma

Protein Gene Product 9.5 (PGP 9.5) Is Not a Specific Marker of Neural and Nerve Sheath Tumors: An Immunohistochemical Study of 95 Mesenchymal Neoplasms

Understanding testing for and treatment of homologous recombination repair (HRR)-mutated metastatic castrate-resistant prostate cancer (mCRPC): A quality initiative by Integra Connect (IC) PrecisionQ

Role of sarA in the Pathogenesis of Staphylococcus aureus Musculoskeletal Infection

Patient Understanding and Impression of Hematology/Oncology Fellows

Comparison of objective criteria for set-up planning in complementary flexible manufacturing systems

BRCA and homologous recombination repair deficiency testing in advanced ovarian cancer: A real-world data analysis

Patterns in maintenance therapy use in advanced ovarian cancer patients: Real-world data analysis

Use of poly (adp-ribose) polymerase inhibitors (PARPi) in metastatic castration resistant prostate cancer (mCRPC) patients stratified by homologous recombination repair mutations

Supporting high-risk oncology patients with an outpatient transitional care management program

Understanding testing for and treatment of homologous recombination repair (HRR)-mutated metastatic castrate-resistant prostate cancer (mCRPC): A quality initiative by Integra Connect PrecisionQ

Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01

A phase 2, multicenter, parallel-group, open-label study of vudalimab (XmAb20717), a PD-1 x CTLA-4 bispecific antibody, alone or in combination with chemotherapy or targeted therapy in patients with molecularly defined subtypes of metastatic castration-resistant prostate cancer

Prognostic value of the “surprise question” among UPMC Hillman Cancer Center patients with select stage IV cancer diagnoses

Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases

The osteoclast-type giant cell rich carcinoma of urinary bladder: A case series

FGFR2/3 genomic alterations (GA) in cell-free (cf)DNA from patients (pts) with advanced urothelial carcinoma (aUC)

Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future

Characterization of a rabbit model of staphylococcal osteomyelitis

Suchergebnisse filtern